Company

Seragon Pharmaceuticals Inc.

Seragon Pharmaceuticals is a San Diego biopharmaceutical company developing gene therapies and AI-driven genomic diagnostics.

About

Founded in 2013 in San Diego, US, Seragon Pharmaceuticals Inc. develops gene therapy, metabolic disorder treatments and deep learning genomic diagnostics for human and animal health. Its partners include healthcare providers, research institutions and pharmaceutical companies in North America, Europe and Asia-Pacific. Genentech, Inc. acquired the company in July 2014, valuing it at up to USD 1.7 billion. The company has completed two deals and its recorded stage is Series A.

1Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in